Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Molecular Partners H1 EPS $(1.05) Down From $4.86 YoY, Sales $3.85M Down From $195.55M YoY

Author: Happy Mohamed | August 24, 2023 04:18pm
Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(1.05) per share. This is a 121.6 percent decrease over earnings of $4.86 per share from the same period last year. The company reported $3.85 million in sales this quarter. This is a 98.03 percent decrease over sales of $195.55 million the same period last year.

Posted In: MOLN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist